Skip to main content
. 2021 Jan 19;96(4):932–942. doi: 10.1016/j.mayocp.2021.01.006

Table 1.

Clinical Characteristics by Outcome (30-day Death and Prolonged Hospitalization)

Variable No Event (N=109) Event (N=70) P
Characteristic
 Age (y), median (Q1-Q3) 59.0 (47.0-70.0) 63.5 (49.0-76.0) .18
 Patient-identified sex, no. (%) .55
 Male 65 (60) 46 (66)
 Female 43 (39) 24 (34)
 Intersex 1 (1) 0 (0)
 Race/ethnicity, no. (%) .24
 White 53 (49) 27 (39)
 African American 4 (4) 5 (7)
 Native American 21 (19) 11 (16)
 Asian 2 (2) 6 (9)
 Hispanic 21 (19) 15 (21)
 Other 8 (7) 6 (9)
 Body mass index (kg/m2), median (Q1-Q3) 30.7 (27.1-36.3) 28.4 (25.2-32.5) .03
COVID-19 symptoms, no. (%)
 Dyspnea, cough 80 (73) 59 (84) .09
 Fever, fatigue, malaise 71 (65) 38 (54) .15
 Gastrointestinal symptoms 37 (34) 17 (24) .17
 Anosmia, dysgeusia 8 (7) 1 (1) .08
Clinical characteristics, no. (%)
 Diabetes mellitus 37 (34) 30 (43) .23
 Hypertension 47 (43) 37 (53) .20
 Chronic kidney disease 10 (9) 11 (16) .18
 Dialysis 3 (3) 2 (3) .97
 Coronary artery disease 8 (7) 9 (13) .22
 Valvular heart disease 5 (5) 3 (4) .92
 Cardiac transplant 2 (2) 2 (3) .65
 Other organ transplant 3 (3) 3 (4) .58
 Chronic obstructive pulmonary disease or asthma 11 (10) 12 (17) .17
 Pulmonary circulation disorder 0 (0) 2 (3) .08
 Chronic liver disease 2 (2) 2 (3) .65
 Cancer 3 (3) 7 (10) .04
 Stroke 5 (5) 9 (13) .04
 Cardiovascular disease (stroke/coronary artery disease) 13 (12) 17 (24) .03
 Current/former smoker 32 (29) 19 (27) .75
Laboratory values, median (Q1-Q3)
 Hemoglobin (g/dL) [n=178] 12.9 (11.3-14.3) 11.1 (9.2-12.4) <.001
 C-Reactive protein (mg/L) [n=169] 72.8 (24.0-134.4) 97.0 (32.1-187.9) .10
 Ferritin (μg/L) [n=163] 615.0 (187.0-932.0) 726.5 (333.5-1282.5) .05
 Serum creatinine (mg/dL) [n=158] 0.9 (0.7-1.2) 1.1 (0.8-2.2) .003
 Troponin (ng/L) [n=133] 9 (6-29) 44 (13-86) <.001
 N-terminal prohormone B-type natriuretic peptide (pg/mL) [n=113] 188 (78-508) 2159 (392-5030) <.001
 D-Dimer (ng/mL) [n=164] 785 (503-1267) 1356 (933-4154) <.001

COVID-19, coronavirus disease 2019; Q, quartile.